Compugen Ltd. (TLV:CGEN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 533.50
-19.60 (-3.54%)
Apr 1, 2025, 4:46 PM IDT
Compugen Market Cap
Compugen has a market cap or net worth of 508.37 million as of April 1, 2025. Its market cap has decreased by -42.00% in one year.
Market Cap
508.37M
Enterprise Value
134.74M
Revenue
101.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
533.50
Market Cap Chart
Since August 11, 2000, Compugen's market cap has increased from 289.89M to 508.37M, an increase of 75.37%. That is a compound annual growth rate of 2.30%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 65.58B |
| Danel (Adir Yeoshua) | 2.20B |
| Kamada | 1.41B |
| Bait Bakfar | 960.19M |
| Novolog (Pharm-Up 1966) | 813.77M |
| Ilex Medical | 700.98M |
| BrainsWay | 637.11M |
| SofWave Medical | 564.43M |